Cargando…
Combination of FOXD1 and Plk2: A novel biomarker for predicting unfavourable prognosis of colorectal cancer
Colorectal cancer (CRC) is a worldwide disease with worse survival. Our objective is to identify previously unrecognized prognostic factors to better evaluate disease progression. Seven GEO datasets were collected and analysed using R software, followed by KEGG enrichment analysis and TFs network co...
Autores principales: | Zong, Yaping, Miao, Yiming, Li, Wenchang, Zheng, Minhua, Xu, Zhuoqing, Gao, Han, Feng, Wenqing, Xu, Zifeng, Zhao, Jingkun, Shen, Lifei, Lu, Aiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189346/ https://www.ncbi.nlm.nih.gov/pubmed/35579380 http://dx.doi.org/10.1111/jcmm.17361 |
Ejemplares similares
-
KLF5 inhibition overcomes oxaliplatin resistance in patient-derived colorectal cancer organoids by restoring apoptotic response
por: Shen, Xiaohui, et al.
Publicado: (2022) -
Intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy: a retrospective study
por: Chen, Fangqian, et al.
Publicado: (2023) -
Small molecule inhibitors from organoid‐based drug screen induce concurrent apoptosis and gasdermin E‐dependent pyroptosis in colorectal cancer
por: Zhang, Yuchen, et al.
Publicado: (2022) -
Cytokine concentration in peripheral blood of patients with colorectal cancer
por: Li, Wenchang, et al.
Publicado: (2023) -
CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer
por: Xu, Zhuoqing, et al.
Publicado: (2018)